事業
バイオテクノロジーと医薬品 In the complex word of investments, JR Capital experts provide the investment community with a unique partnership to identify and qualify bio-pharmaceutical investment opportunities. Our strength is in the analysis of cross border scientific, regulatory, intellectual property and other related components of investment target.
Our business strategy is designed for maximizing clinical and commercial potential of our product portfolio with our global platform. Through our approach, we have created a pipeline of marketed products and development-stage assets that we believe will provide us and our partners with diversified long-term revenue stream.
医療機器 For the past ten years, JR Capital has been an innovative play to help funding entrepreneurs to grow their business in medical devices business. We are actively in the segments of IVD, hemodialysis center, neurosurgery supplies, orthopedic implant and ophthalmic supplies.
ヘルスケアサービス JR Capital is one of the industry leaders in privatizing stated owned hospitals in China. JR Capital has invested into and helped to build a number of specialist chain hospitals in the field of ophthalmology, orthopaedic and rehabilitation. As an investment banking firm, JR Capital has advised more than 10 hospitals to become public listed entities.
バイオテクノロジーと医薬品 In the complex word of investments, JR Capital experts provide the investment community with a unique partnership to identify and qualify bio-pharmaceutical investment opportunities. Our strength is in the analysis of cross border scientific, regulatory, intellectual property and other related components of investment target.
Our business strategy is designed for maximizing clinical and commercial potential of our product portfolio with our global platform. Through our approach, we have created a pipeline of marketed products and development-stage assets that we believe will provide us and our partners with diversified long-term revenue stream.
医療機器 For the past ten years, JR Capital has been an innovative play to help funding entrepreneurs to grow their business in medical devices business. We are actively in the segments of IVD, hemodialysis center, neurosurgery supplies, orthopedic implant and ophthalmic supplies.
ヘルスケアサービス JR Capital is one of the industry leaders in privatizing stated owned hospitals in China. JR Capital has invested into and helped to build a number of specialist chain hospitals in the field of ophthalmology, orthopaedic and rehabilitation. As an investment banking firm, JR Capital has advised more than 10 hospitals to become public listed entities.
バイオテクノロジー投資
バイオテクノロジーライセンスビジネスは急成長を経験中
中国のバイオテクノロジー産業は10年以上の発展を積み重ねてきました。急速な発展に大きなチャンスの転機を迎えています。多数のイノベーションがバイオテクノロジー産業のブームを追い込み、最も効果的な現代医薬品の不足状況が変わりつつあります。中国政府は革新的なバイオ企業を強力にサポートし、新しい経済成長のポイントとしてバイオ医薬品を開発するために、包括的な一連の科学技術計画を実施しています。
詳しく見る
ニュースルーム
詳しく見る
Two More Pharmas Practice Their Accent, Invest in $75M Series C Round
January 24 , 2024
詳しく見る
Sanofi to Acquire Inhibrx, Inc., Adding Potential Best-in-class Rare Disease Asset for Alpha-1 Antitrypsin Deficiency to Pipeline January 23 , 2024詳しく見る
Gilead Provides Update On Phase 3 EVOKE-01 Study January 22 , 2024詳しく見る